BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 33435254)

  • 1. Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer.
    Wu HJ; Chu PY
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction.
    Kashyap D; Kaur H
    Life Sci; 2020 Apr; 246():117417. PubMed ID: 32044304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
    Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
    J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subtypes of screen-detected breast cancer.
    Farshid G; Walters D
    Breast Cancer Res Treat; 2018 Nov; 172(1):191-199. PubMed ID: 30046938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival.
    Inwald EC; Koller M; Klinkhammer-Schalke M; Zeman F; Hofstädter F; Gerstenhauer M; Brockhoff G; Ortmann O
    Breast Cancer Res Treat; 2015 Oct; 153(3):647-58. PubMed ID: 26369534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
    Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
    Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative tissue proteomic investigation of invasive ductal carcinoma of breast with luminal B HER2 positive and HER2 enriched subtypes towards potential diagnostic and therapeutic biomarkers.
    Pendharkar N; Gajbhiye A; Taunk K; RoyChoudhury S; Dhali S; Seal S; Mane A; Abhang S; Santra MK; Chaudhury K; Rapole S
    J Proteomics; 2016 Jan; 132():112-30. PubMed ID: 26642762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up.
    Falck AK; Röme A; Fernö M; Olsson H; Chebil G; Bendahl PO; Rydén L
    Br J Surg; 2016 Apr; 103(5):513-23. PubMed ID: 26856820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of cancer/testis antigens (CTAs) in breast cancer.
    Li Y; Li J; Wang Y; Zhang Y; Chu J; Sun C; Fu Z; Huang Y; Zhang H; Yuan H; Yin Y
    Cancer Lett; 2017 Jul; 399():64-73. PubMed ID: 28274891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.
    Kobayashi N; Hikichi M; Ushimado K; Sugioka A; Kiriyama Y; Kuroda M; Utsumi T
    Clin Transl Oncol; 2017 Oct; 19(10):1232-1240. PubMed ID: 28409323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphological features of basal-like subtype invasive carcinoma of breast].
    Gao LX; Yang GZ; Ding HY; Li L
    Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):83-7. PubMed ID: 18681317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged survival after diagnosis of brain metastasis from breast cancer: contributing factors and treatment implications.
    Honda Y; Aruga T; Yamashita T; Miyamoto H; Horiguchi K; Kitagawa D; Idera N; Goto R; Kuroi K
    Jpn J Clin Oncol; 2015 Aug; 45(8):713-8. PubMed ID: 25981620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA Expression Profiles in Luminal A Breast Cancer-Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment.
    Kudela E; Samec M; Koklesova L; Liskova A; Kubatka P; Kozubik E; Rokos T; Pribulova T; Gabonova E; Smolar M; Biringer K
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33080858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer.
    Kim GE; Lee JS; Choi YD; Lee KH; Lee JH; Nam JH; Choi C; Kim SS; Park MH; Yoon JH; Kweon SS
    BMC Cancer; 2014 Dec; 14():959. PubMed ID: 25510449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast.
    Narbe U; Sjöström M; Forsare C; Bendahl PO; Alkner S; Leeb-Lundberg LMF; Lövgren K; Rydén L; Ingvar C; Fernö M
    Breast Cancer Res Treat; 2019 Jun; 175(2):305-316. PubMed ID: 30796653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of different tumour subtypes on management and survival of New Zealand women with Stage I-III breast cancer.
    Lawrenson R; Lao C; Campbell I; Harvey V; Seneviratne S; Elwood M; Sarfati D; Kuper-Hommel M
    N Z Med J; 2018 May; 131(1475):51-60. PubMed ID: 29771902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
    Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
    Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
    Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
    Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.